IDH1 Non-Canonical Mutations and Survival in Patients with Glioma.
Enrico FranceschiDario de BiaseVincenzo Di NunnoAnnalisa PessionAlicia TosoniLidia GattoGiovanni TalliniMichela VisaniRaffaele LodiStefania BartoliniAlba Ariela BrandesPublished in: Diagnostics (Basel, Switzerland) (2021)
the presence of non-canonical IDH1 mutations could be associated with improved survival among patients with IDH1 mutated grade II-III glioma.